Campus Virchow Klinikum

Berlin 13353

0 studies enrolling now · 2 studies all time

What they study most

Chronic Hepatitis C, Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed